Judith K. Jones, MD, PhD

President and Founder

Dr. Judith K. Jones is a clinical pharmacologist / pharmacoepidemiologist and geriatrician/internist with a long-standing interest in the study of adverse drug reactions, drug utilization, and drug development and regulation. She received her medical training at Baylor College of Medicine in Houston, Texas, followed by clinical training, a fellowship in clinical pharmacology and a PhD in developmental pharmacology at University of California at San Francisco.

In the 1970’s, interested in the translation of basic pharmacology information to the practice site, Dr. Jones practiced, taught clinical pharmacology and carried out early research in drug utilization at Pacific Medical Center in San Francisco. In 1978, she came to Washington, DC as Director of the FDA’s Division of Drug Experience (now Epidemiology) until 1984, and was then Special Asst. to the Director, Biometrics and Epidemiology through mid-1985.

Leaving the FDA, she returned to practice in 1985 in Medicine and Geriatrics at Georgetown University, where she continues as Associate Clinical Professor of Pharmacology. She is also Adjunct Professor of the Health Sciences at George Washington University, and is also Adjunct at the University of Michigan School of Public Health's Summer Program where she teaches a course in Pharmacoepidemiology.

In 1988, she founded The Degge Group, Ltd., a consulting business that provides services relating to drug safety information, regulation, research and education. Dr. Jones also serves as President of the Pharmaceutical Education and Research Institute, Inc. (PERI) that was founded in 1989 by PhRMA .

Dr. Jones has published a number of articles relating to adverse reactions, post-marketing surveillance of drugs, pharmaceutical risk management, drugs in geriatric patients, and drug information for patients and physicians.

 

Expertise at The Degge Group

Degge's diverse group of dedicated professionals  are able to provide services in a number of areas relating to drug and medical product safety, regulation and epidemiology. The Research, and Regulatory /Legal Divisions at the Degge Group are staffed with highly experienced epidemiologists, analysts, pharmacists, and researchers who are committed to excellence.

Selected specific areas of expertise include:

• Consulting in regulatory pharmaceutical and other medical product safety issues
• Analysis of Adverse Reactions Data from the FDA's AERs data, and the World Health Organization (WHO)
• Regulatory Audits - SOP development, internal reviews, benchmarking
• Design and conduct of epidemiologic studies (of drug risks or disease natural history) in a number of large medical claims or electronic databases in the US, Canada, UK and elsewhere
• Design and implementation of pharmaceutical risk management efforts in collaboration with key partners, including LAMA (Louis A. Morris & Associates) and Dendrite International
• Development of multi-media information for patients (e.g., KidzwithLeukemia CD-ROM)
• Protocol and CRF development - controlled and observational clinical trials, registries, surveys
• Statistical and clinical data analysis - controlled and observational clinical trials, medical claims databases, adverse events, modeling and simulation
• Survey design - patient and physician questionnaires
• Literature analysis - systematic searches and evidence-based evaluations
• Legal Affairs - medico-legal research and expert testimony